COVID-19

January 2, 2024

Team uses COVID-19 to test automated acute disease profiling

An automated solution for creating phenotyping algorithms, PheNorm, worked well to identify symptomatic COVID-19 cases in electronic health records, suggesting that automation could speed high-throughput phenotyping of acute disease.

November 6, 2023

Children’s antibodies highly potent against COVID-19: study

Reporting Nov. 6 in Cell Reports Medicine, Ivelin Georgiev, PhD, and colleagues demonstrated that antibodies isolated from children’s blood samples displayed high levels of neutralization and potency against variants of the COVID-19 virus, SARS-CoV-2, even when the children had not previously been exposed to or vaccinated against those variants.

September 19, 2023

Updated COVID-19 vaccine available for VUMC employees and patients

The Food and Drug Administration (FDA) recently approved an updated mRNA COVID-19 vaccine. The vaccine provides better protection against current strains of COVID-19 that are circulating as we transition into the fall/winter virus season.

September 13, 2023

James Crowe’s antibody research lands American Society for Microbiology Award

Vanderbilt University Medical Center’s James Crowe Jr., MD, has been named to receive the 2024 American Society for Microbiology Award for Applied and Biotechnological Research.

Rebecca Plowman, RN, was among the speakers discussed how the COVID-19 pandemic impacted front-line health care providers.
August 23, 2023

How caregivers can reclaim what COVID-19 took away

Vanderbilt University Medical Center hosted an online “Bedside Matters” to discuss the toll the COVID-19 pandemic has taken on front-line providers of health care.

August 2, 2023

VUMC receives $28 million to lead national study of COVID-diabetes link

Researchers at Vanderbilt University Medical Center have received a four-year, $28 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to study the relationship between COVID-19 and diabetes.